Prevalence of migraine among adults with mood disorders: a Saudi cross-sectional study.
Ahmad H Almadani, Ayedh H Alghamdi, Abdulelah A Bashandi, Badr M Alqarni, Falwah S Alsalman, Abdulrahman I Binbakhit, Ziyad B Alenazi, Elaaf A Albadi, Noorah E Alkhilaiwi, Yara A Alfarraj, Abdullah K Muhnna, Mohammed A Aljaffer
Abstract
Open AccessBACKGROUND: Migraine is characterized by recurrent headaches and frequently coexists with depressive and bipolar disorders, exacerbating disability and complicating management. Data on this association in Saudi Arabia remain limited, however. OBJECTIVES: This study aims to investigate how mood disorders and migraine occur together in the Saudi context and understand the extent of disability that migraine may cause in patients with mood disorders. METHODS: A cross-sectional study was conducted involving adult patients with mood disorders at a tertiary hospital in Riyadh, Saudi Arabia. Participants were recruited through convenience sampling. The research instrument consisted of a questionnaire developed by the research team to assess sociodemographic factors, along with the Arabic version of the Migraine Screen Questionnaire (MS-Q) for migraine screening and the Arabic version of the Migraine Disability Assessment Scale (MIDAS) to quantify migraine-related disability. RESULTS: A total of 206 participants were included, 10.68% of whom had a prior diagnosis of migraine and 20.87% screened positive for migraine on the MS-Q. The average MS-Q score was 1.48 ± 1.86 and MIDAS score 6.81 ± 19.3, indicating mild to moderate disability. Among those with migraine, 31.25% had severe migraine-related disability. The multivariate analysis identified female sex, psychiatric comorbidity, sleep quality, and family history of migraine as significant predictors for migraine. There was no correlation with age, income, employment status, snoring, or mood disorder type. CONCLUSION: The results confirm that migraine is a prevalent and disabling comorbidity among individuals with mood disorders, with female sex, family history of migraine, poor sleep quality, and psychiatric comorbidities increasing the risk of migraine. Thus, routine migraine screening in psychiatric settings may improve diagnosis, management, and patient outcomes. CLINICAL TRIAL NUMBER: Not applicable.